Medtronic
Medtronic Quality Analysis
Medtronic (MDT) is an average quality business scoring 62/100. While the company generates positive returns, it lacks the exceptional attributes that characterize durable competitive advantages. Investors should demand a meaningful discount to fair value before investing.
Does Medtronic have a strong competitive moat?
Medtronic shows a solid competitive position with solid gross margins of 65.9%. However, returns on capital that fall short of elite levels suggests the moat, while present, may face challenges. The business earns above-average returns but lacks the exceptional durability of the strongest moats.
Does Medtronic have pricing power in its industry?
Medtronic has limited pricing power. The company operates with margins that are average for its industry, and revenue growth has come with some margin pressure. This suggests the business competes partially on price rather than on differentiated value.
How predictable is Medtronic's business?
Medtronic offers good predictability. Revenue and cash flows have followed a generally consistent pattern over recent years. Minor fluctuations have occurred, but the overall trend is reliable. The business model produces reasonably forecastable results.
Is Medtronic financially strong?
Medtronic has an exceptionally strong balance sheet with a conservative debt-to-equity ratio of 0.00x. The company could comfortably weather a severe economic downturn. This financial fortress provides strategic flexibility and reduces risk for long-term shareholders.
How effective is Medtronic's capital allocation strategy?
Medtronic shows poor capital allocation with returns on capital that fall below acceptable levels. Capital is being deployed in ways that may destroy shareholder value rather than create it. This is a significant red flag for long-term investors.
Does Medtronic have high-quality management?
Medtronic has competent management that delivers acceptable results. Returns on capital are reasonable and operations run efficiently. While not exceptional, the management team maintains a steady hand and does not appear to be making value-destructive decisions.
Is Medtronic a quality company?
Medtronic is an average quality company with a quality score of 62/100
Predicted probability of operating margin improvement over the next 12 months
- Financial strength is the strongest dimension at 92/100.
- Capital allocation is the weakest area at 39/100 and needs attention.
- Average gross margin of 65.9% over 5 years.
- Positive free cash flow in 7 of the last 7 years.
- Debt-to-equity ratio of 0.00x.
What is the fair value of Medtronic stock?
Is Medtronic a good investment at $87?
The following analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. The opinions expressed are based on publicly available information and historical data. Beanvest and its contributors may hold positions in the securities mentioned. Investors should conduct their own due diligence or consult a licensed financial advisor before making any investment decision.